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ABSTRACT 
Since the dawn of massively parallel sequencing technologies in mid-2000s their utility in 
profiling the expression of genes in a genome-wide fashion has matured and progressed from 
cell populations to individual cells. In particular, single-cell RNA sequencing (scRNA-seq) 
has impacted numerous domains in life sciences and hold immense promise in biology and 
medicine. Indeed, it has become realistic to chart the complete set of cell types and states in 
multicellular organisms, and projects have started to map out cell types in humans (i.e. the 
Human Cell Atlas project) and model organsims. In this thesis, I present the application of 
scRNA-seq to infectious disease and cancer as well as a computational assessment of the 
general possibilities and limitations of scRNA-seq for enumerating cell types and states de 
novo. In Paper I, we describe the ability of scRNA-seq to profile transcriptomes from 
individual malaria-causing P. falciparum parasites. We reveal heterogeneity even among 
synchronized cultures of parasites during their red blood cell life cycle. Moreover, we 
identify a subset of sexually differentiated P. falciparum with a distinct gene signature, likely 
important for parasite transmission that may be exploited for the design of transmission-
blocking drugs and/or vaccines. In Paper II, I present a computational strategy to identify the 
magnitude of biological gene expression differences needed for accurate inference of cell 
identities using scRNA-seq. Interestingly, rather large differences are needed for proper cell 
state discrimination, irrespective of scRNA-seq protocol, implying that large number of cell 
states may escape detection. In Paper III, we used scRNA-seq and bulk RNA-seq to 
characterize the molecular programs during the later stages of lung metastasis. We 
demonstrate that a transition from epithelial to mesenchymal cell characteristics occurs in 
cancer cells during metastasis, and that the mesenchymal properties are maintained during 
metastasis growth extending over a week. In Paper IV we performed transcriptome analyses 
on stem and progenitor populations in myelodysplastic syndrome (MDS) patients. We 
provide evidence that the MDS stem cells and the progenitors have distinct transcriptome. 
Altogether, this thesis expands the applications of scRNA-seq towards parasite biology and 
cancer metastasis and we provide valuable insights into the abilities of current scRNA-seq 
technologies in mapping cell states in an unbiased fashion. 
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1 BACKGROUND 
1.1 EUKARYOTES: FROM UNICELLULAR TO METAZOAN ORGANISMS 
The cell is the fundamental unit of life and understanding it at a molecular level is critical in 
both microbial and complex organisms. Mammalian systems for instance, are made up of 
functionally specialized tissues and organs that encompass a heterogeneous mix of distinct 
and dynamic types, subtypes and states. In spite of having identical genomes most 
mammalian cells adopt specialized form and function that augments the complexity of these 
organisms (Alberts et al. 2014; Chen & Dent 2014; Levine & Tjian 2003). Also, 
communities of single celled eukaryotes (e.g. malaria parasites) undergo remarkable 
transitions in form and function in response to stimuli and developmental progression in order 
to thrive in different environments (Cowman et al. 2016; Cowman et al. 2017). Hence, 
intricate regulation of gene expression is a crucial component to eukaryotic life.                                                
1.2 GENE EXPRESSION AND REGULATION IN EUKARYOTES 
The genetic blueprint of a cell is encoded in its genome and this defines its molecular 
potential. Given that genomes act as blueprint, the encoded information must be transmitted 
into functional molecular entities in order for it to be useful. In eukaryotes, the flow of 
information from the genome to the final functional elements is commonly referred to as the 
central dogma (see figure 1a) and entails RNA transcription, processing, transport, 
stabilization, translation and protein activation (Alberts et al. 2014). This multistep process is 
complex and can in principle be regulated at any of the enlisted steps. However, 
transcriptional control is most critical since it prevents wasteful production of transcripts in a 
given cell (Alberts et al. 2014).                               
The set of transcribed genes and their corresponding expression levels are important in 
determining cells properties. This is controlled at multiple levels such as epigenetic, 
transcriptional and post-transcriptional regulation (Coulon et al. 2013; Holoch & Moazed 
2015; Klemm et al. 2019; Spitz & Furlong 2012). The epigenetic landscape of a cell is an 
important factor involved in defining the differentiation state. Given the tight packaging of 
DNA around nucleosomes and higher order chromatin structures, transcription involves 
remodeling of the closed chromatin region (heterochromatin) into open euchromatin to 
facilitate accessibility by the transcription machinery (Alberts et al. 2014). Additionally, the 
overall chromatin accessibility is key in determining the transcriptional activity of a gene. 
ATP dependent chromatin remodelers facilitate this through post-translational modification 
of histones, histone variants, DNA modification and non-coding RNAs (Alberts et al., 2014; 
Chen & Dent, 2014). The epigenetic status of a genic region is dynamic and might be defined 
in a spatial-temporal fashion depending on the cell type/state, external stimuli, position, and 
differentiation stage among others (Alberts et al. 2014; Klemm et al. 2019). 
For euchromatic genes to be transcribed, general transcriptional factors (GTFs), RNA 
polymerases and several other regulatory proteins are involved (Alberts et al., 2014). In the 
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nucleus, genes are transcribed into RNA transcripts that can function as intermediates for 
protein synthesis (messenger RNA), regulatory RNAs (lincrRNA, microRNA), processing 
factors (small nuclear RNAs), RNA transport, translation (ribosomal RNA and transfer RNA) 
and degradation (piRNA). RNA only occupies 10% of the cellular volume where the majority 
are rRNAs (about 80%) and mRNAs 5-10% (Alberts et al., 2014). Unlike prokaryotes, 
eukaryotes have three RNA polymerases namely: I, II and III. Only RNA polymerase II (Pol 
II) catalyzes mRNA synthesis. For Pol II to initiate transcription, the general transcription 
factors (TFIIA, TFIIB, TFIIC, TFIID, etc) are recruited to the proximal promoter thereby 
forming the basal transcription initiation complex (Alberts et al. 2014; Haberle & Stark 
2018). For most genes, transcription is further regulated by multiple cis regulatory elements 
that are bound by specific transcriptional factors (trans acting factors) (Alberts et al. 2014; 
Haberle & Stark 2018; Zabidi & Stark 2016). Additionally, co-activators and co-repressors 
may play a role (see figure 1b). Pol II recruitment is critical and normally effected by several 
specific transcriptional factors (STFs) acting proximally or distally to the target gene. DNA 
looping makes it possible for distally located STFs to regulate genes independent of direction 
and distance. Additionally, insulators demarcate transcriptional domains to prevent non-
specific action. These STFs act in combinatorial and context dependent fashion to enable 
diverse responses to stimuli. Regulatory factors may influence gene transcription in a variety 
of ways namely: remodeling chromatin structure, influencing transcriptional machinery 
assembly, control Pol II release and pausing (Alberts et al., 2014).  
Once Pol II driven transcription terminates, the new transcripts are processed into mature 
mRNA for transport and translation in the cytoplasm. This processing adds another layer of 
regulation and involves for example 5’- capping, 3’-polyadenylation and splicing (Alberts et 
al. 2014; Hocine et al. 2010). For instance, alternative splicing allows for a single gene to 
encode distinct isoforms which would generate variant while capping and polyadenylation 
are key in the transport and stabilization of RNA transcripts. 
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1.3 DNA SEQUENCING 
De novo sequencing of the human genome, several model organisms and important disease 
causing agents were carried out by the laborious, expensive and low throughput Sanger 
sequencing technique using a whole genome/chromosome shotgun approach (International 
Human Genome Sequencing Consortium 2001; International Human Genome Sequencing 
Consortium 2004; Adams et al. 2000; Arabidopsis Genome Initiative 2000; C. elegans 
Sequencing Consortium 1998; Mouse Genome Sequencing Consortium et al. 2002; 
Fleischmann et al. 1995; Gardner et al. 2002). The emergence of massively parallel 
sequencing technologies in the mid-2000s instigated the genome-wide molecular examination 
of biological processes. This resulted in a massive increase in throughput, reduction in labour 
and reductions of up to 50,000-fold in sequencing cost relative to the human genome project 
(Goodwin et al. 2016). These techniques that have been referred to as next generation 
sequencing (NGS) technologies and each has its distinguishing chemistry. Their marked leap 
from the first generation chain termination approaches such as Sanger sequencing was the 
ability to carry out massively parallelized reactions and detect signals in miniaturized reaction 
centers without the DNA cloning step (Goodwin et al. 2016; Metzker 2010; Shendure et al. 
2017). These advances in NGS technologies have played a critical role in opening up 
genomics field for intriguing biological pursuits such as genetic variation, epigenomics and 
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RNA expression (Metzker 2010; Shendure et al. 2017; Shendure et al. 2019). Most of these 
studies were based on an ensemble of cells that made it unattainable to tackle studies that 
required single cell resolution. However, the last decade has ushered in genome-wide single 
cell methods that utilize NGS in their workflow to interrogate gene expression (Sandberg 
2013; Shapiro et al. 2013). 
Roche/454 pyrosequencing NGS platform was the first to be commercially distributed and 
followed by multiple technologies namely: Illumina/Solexa sequencing by synthesis, Ion 
Torrent, Helicos, and BGI’s Complete Genomics (Goodwin et al. 2016; Metzker 2010). 
These have been referred to as the second generation (or short reads) sequencing technologies 
and vary in their chemistry, read lengths, error rates, throughput and base calling. 454 
platform utilizes emulsion PCR to clonally amplify DNA template attached to a bead in nano-
sized well then detect emitted light signal from a luciferase and pyrophosphate driven 
reaction cascade. Ion torrent detects pH changes from the released H+ ions. Illumina 
sequencing by synthesis uses a cyclic-reversible termination strategy with imaging of the 
added flour-bound deoxynucleotide.  
While the second generation NGS platforms rely on clonally amplified DNA fragments to 
generate sufficient signal for detection, third generation methods sequence very long reads 
without the need for amplification. The two prominent technologies are real-time single-
molecule sequencing and nanosequencing by Pacific Biosciences (PacBio) and Oxford 
Nanopore Techonogies (ONT). PacBio relies on optical detection of the flourophore signal 
released from incorporated nucleotide during DNA polymerase synthesis of the growing 
DNA strand (Goodwin et al. 2016). Unlike the short reads sequencing-by-synthesis 
approaches, the target DNA template strand is bound to a fixed DNA polymerase and using 
zero mode waveguide ensures that only one nucleotide is added and detected per time. ONT 
exploits the ionic changes that occur when single DNA strand is passed through tiny protein 
pore and reads template sequence based on the generated electric signal (Goodwin et al. 
2016). Unlike other platforms ONT reads the native sequence of the template DNA and does 
not depend on detecting signals such as pH, color or light. Since ONT relies on electric signal 
detection there is no need for highly specialized optics and the platform is therefore attractive 
in remote settings with poor infrastructure. Both PacBio and ONT technologies generate very 
long sequence reads, typically 10kb or more, and may facilitate the detection of covalent 
DNA modifications (Flusberg et al. 2010; Wescoe et al. 2014). However, in comparison to 
the second generation NGS platforms they still suffer from substantial error rates. Hence 
these platforms could complement other NGS platforms such as Illumina. With continued 
improvements in terms of throughput and sequencing errors minimization, these technologies 
might catalyze genome-wide studies such as structural variation, splicing and allelic variation 
at the single-cell level. The recent acquisition of PacBio by Illumina could potentially lead to 
improved long reads sequencing platforms (Eisenstein 2019). 
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2 SINGLE-CELL GENE EXPRESSION ANALYSES 
2.1 INTRODUCTION 
Over the last decade, scRNA-seq has blossomed and transitioned from a proof-of-concept to 
addressing intriguing biological questions in development (Petropoulos et al. 2016; Xue et 
al. 2013), gene regulation (Deng et al. 2014; Reinius et al. 2016) and infectious disease 
(Poran et al. 2017; Reid et al. 2018) among others. scRNA-seq can elucidate regulatory 
networks which might not be possible with the ensemble-based methods, for example in 
instances where two factors regulate a set of genes independently (Shalek et al. 2014; 
Trapnell et al. 2014; Zeisel et al. 2015). Another emerging and equally exciting application 
is the inference of transcriptional kinetic parameters at allelic resolution (Larsson et al. 
2019). However one of the most established applications of scRNA-seq has been in the 
characterization and discovery of sub-populations of cells and transitory developmental states 
(Wagner et al. 2016). 
2.2 TRADITIONAL METHODS FOR SINGLE-CELL GENE EXPRESSION 
ANALYSES 
In the early years of single-cell gene expression profiling, low throughput techniques were 
commonly used to profile a target set of genes. These included the use of fluorescent reporter 
constructs (Chalfie et al. 1994; Young et al. 2012), quantitative PCR (Bengtsson et al. 2008; 
Taniguchi et al. 2009; Warren et al. 2006; Wills et al. 2013), and single-molecule RNA 
FISH (Femino et al. 1998; Raj et al. 2008). While these methods have facilitated some 
critical findings (Wills et al. 2013), they are limited to the detection of few numbers of genes. 
Following the emergence of microarray technique, single cell profiling of all annotated 
transcriptomes after amplification of the cellular transcripts was implemented on this 
platform (Kamme et al. 2003; Kurimoto et al. 2006; Subkhankulova et al. 2008). However, 
the appearance of massively parallel sequencing platforms ushered in RNA sequencing 
initially for bulk then single cell profiling of transcriptomes in unbiased and high throughput 
fashion. The first single cell RNA sequencing (scRNA-seq) study was published in 2009 
(Tang et al. 2009) and followed by several improved techniques (Kolodziejczyk et al. 2015). 
2.3 SINGLE-CELL RNA-SEQUENCING 
Over the past decade, several protocols have been developed for capturing, converting and 
amplifying the limited mRNA transcripts from single cells (Lafzi et al. 2018; Picelli 2016; 
Chen et al. 2018; Svensson et al. 2017). Out of these, some have gained wide prominence 
namely: CEL-Seq (Hashimshony et al. 2012), CEL-Seq2(Hashimshony et al. 2016), Drop-
seq (Macosko et al. 2015), MARS-seq (Jaitin et al. 2014), STRT (Islam et al. 2011; Islam et 
al. 2014), STRT-2i (Hochgerner et al. 2017), Smart-seq (Ramskold et al. 2012), Smart-seq2 
(Picelli et al. 2013), SCRB-seq (Bagnoli et al. 2018; Soumillon et al. 2014), Quartz-seq 
(Sasagawa et al. 2013), Quartz-seq2 (Sasagawa et al. 2018), inDrop (Klein et al. 2015), sci-
RNA-seq (Cao et al. 2017) and SPLiT-seq (Rosenberg et al. 2018).  While these protocols 
differ in their processing steps, the samples are often derived from tissues, organs, cultured 
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cells or microbes. In the case of solid tissues, the first step is to disaggregate the sample into 
small pieces and then dissociate it into single cells suspension using proteases. Individual 
cells are then isolated from the suspension using one of the different methods namely: manual 
picking (using micropipettes), fluorescence-activated cell sorting (FACS) into plates or 
automated capture in nanolitre chambers in droplets or microwells. Additionally, in vitro cell 
pickers combined with computer vision techniques are becoming useful (Környei et al. 2013; 
Ungai-Salánki et al. 2016). These approaches differ in terms of their throughput, reagent 
volumes and labour intensity. The recent advent of single-cell combinatorial indexing 
techniques in combination with multiple rounds of sample pool-split strategy have made it 
possible to profile large number of single cells without the need for specialized equipment for 
automated (Cao et al. 2017; Rosenberg et al. 2018).  
Once isolated, individual cells can be lysed using hypotonic solution in the presence of 
RNAse inhibitors to prevent transcripts degradation. A majority of protocols target 
polyadenylated mRNA transcripts using polyT oligonucleotides primers and then generate 
complementary DNA strands (cDNA) through a reverse transcriptase catalyzed synthesis 
process. There are three main second strand synthesis strategies: poly A tailing using terminal 
transferase activity (Quartz-seq, Quartz-seq2 and Tang et al), template-switching (Smart-seq, 
Smart-seq2, Chromium (10x Genomics) (Zheng et al. 2017), STRT-seq, Seq-Well (Gierahn 
et al. 2017)) and combination of Ribonuclease (RNase H) with DNA pol I from E. coli (CEL-
seq, CEL-seq2, MARS-seq, inDrop and sci-RNA-seq). Given the limited amount of material 
the cDNA is amplified using an in vitro transcription (IVT) strategy (CEL-seq, CEL-seq2 and 
inDrop) with remaining ones using PCR approach. Unlike PCR approaches IVT attains linear 
amplification hence reducing amplification bias. However, the multiple steps involved IVT 
approach is time consuming. While Quartz-seq, Smart-seq and Smart-seq2 capture fragments 
from across the entire transcript length the other protocols only tag 5’- or 3’-ends and referred 
to as end counting methods. In order to overcome amplification bias, the end counting 
methods often use Unique Molecular Identifiers (UMIs) that are short nucleotide sequences 
which act as barcodes for keeping track of the absolute counts of transcripts pre-
amplification. While the use of UMIs makes end counting methods attractive for studies that 
mainly depend on quantifying gene expression levels, the inability to sample fragments from 
the entire transcript body is a drawback for studies aimed at allelic expression resolution and 
splicing isoform analysis. 
In all protocols, profound caution is required when preparing and processing the libraries in 
order to impede the loss of already limited material. Some of the measures often taken 
include pooling of indexed samples, combining multiple steps into single reaction, avoiding 
unnecessary transfer of reaction mixes and working in ice-cold conditions when processing 
samples.  
In spite of the measures described above, technical noise is inevitable in scRNA-seq and 
specific experimental & analysis strategies must be considered when designing studies so as 
to minimize their impact on the biological signal. One of the common strategies aimed at 
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tackling technical noise is to include a set of spike-in control mRNAs, to experimentally 
distinguish the technical noise level from biological variability (Brennecke et al. 2013; Grün 
et al. 2014; Grün et al. 2015). Spike-ins are exogenous RNAs added in known amounts per 
cell lysate before cDNA generation and processed together with the endogenous mRNA 
transcripts. Since they are added in equal amounts per sample any variability in their 
expression measurements should represent the magnitude of technical noise. Ideally, the 
abundances of individual spike-in species should span the dynamic range of the target cells 
gene expression, reflect the endogenous genes properties (such as GC content, polyA tail 
length and gene size) and be properly calibrated. One of the commonly used spike-in is 
ERCC’s synthetic set of 92 bacterial derived transcripts (Consortium et al. 2005; Grün et al. 
2014). Some experiments have demonstrated the use of transcripts from species unrelated to 
the cells under investigation (Brennecke et al. 2013). While broadly used in scRNA-seq, 
spike-ins often have pitfalls and deconvolving technical noise from their measurements can 
be difficult. Their properties could be non-reflective of the endogenous transcripts (e.g. 
shorter polyA tails in ERCC spike-ins), cannot track any variations that occur before the 
reverse transcription step and are usually technically challenging to calibrate especially for 
small cells with minute amounts of RNA. In some studies, modeling the relationship between 
mean and the coefficient of variation of endogenous genes and statistically calculating 
candidates with noise beyond the expected variance can be useful (Buettner et al. 2014).  
Several factors contribute towards technical noise in scRNA-seq studies, namely: non-
uniform cell lysis, RT efficiency, amplification, sequencing, contaminations and processing 
batch effects (Grün et al. 2014; Vallejos et al. 2015; Wagner et al. 2016). Due to the small 
amounts of starting material, transcript dropouts (i.e. genes that are transcribed but fail to be 
captured due to technical reasons) are prevalent, hence leading to sparse gene expression 
matrices. This is a hallmark of scRNA-seq data and poses vital analytical challenge that must 
be taken into consideration (Kharchenko et al. 2014). Dropout rates vary across protocols 
though it is higher per cell in the less sensitive end counting methods (estimated sensitivity 
ranges between 5% and 40%). Full-length coverage by protocols such as Smart-seq2 (Picelli 
et al., 2013) sample fragments from the entire transcript body thus substantially improving 
their sensitivity per cell. This makes them suitable for studies requiring allele-resolved 
expression or the detection of lowly expressed genes. However, the recent upscaling of cell 
numbers by end counting methods on droplet microfluidics (Zheng et al., 2017) and 
combinatorial indexing implementations (Cao et al. 2017; Rosenberg et al. 2018), presently 
in the thousands and more, augments their power to detect technical dropouts. The recent 
adoption of split-pool strategy with combinatorial indexing, substantially increases 
throughput in terms of cell numbers without the requirement for specialized cell isolation 
equipment. This may make these approaches attractive to low-resourced research units and 
for studies targeting enormous cell numbers such as whole tissue or organism profiling (Cao 
et al. 2019).  
Given the substantial number of scRNA-seq protocols it is important to reflect on which 
method would be most suitable in a study. Some of the guiding factors could be: the research 
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question at hand, financial standing, accessibility to specialized equipment and computational 
resources. Previous benchmarking efforts may also provide useful insights (Svensson et al. 
2017; Ziegenhain et al. 2017). For some research pursuits, two or more protocols might be 
beneficial. For instance, in subtype discovery end counting protocols on automated platform 
may be used initially to generate low coverage transcriptomes from large cell numbers at 
shallow sequencing. Next, applying a high-depth/sensitive protocol to a subset of cells would 
give an exhaustive molecular understanding of the biological quest. 
     
Figure 2: The single-cell RNA sequencing process. The design of single-cell transcriptomics experiments 
includes four major phases: (1) During sample preparation, cells are physically separated into a single-cell 
solution from which specific cell types can be enriched or excluded (optional). After they have been captured in 
wells or droplets, single cells are lysed, and the RNA is released for subsequent processing. (2) To convert RNA 
into sequencing-ready libraries, poly(A)-tailed RNA molecules are captured on poly(T) oligonucleotides that can 
contain unique molecular identifier (UMI) sequences and single-cell-specific barcodes (5′- and 3′-biased 
methods). To allow for subsequent amplification of the RNA by PCR or IVT, adaptors or T7 polymerase 
promoter sequences, respectively, are included in the oligonucleotides. After RT into cDNA and second-strand 
synthesis (optional), the transcriptome is amplified (PCR or IVT). For conversion into sequencing libraries, the 
amplicons are fragmented by enzymatic (e.g., tagmentation) or mechanical (e.g., ultrasound) forces. Sequencing 
adaptors are attached during a final amplification step. Full-length sequencing can be carried out, or 5′ or 3′ 
transcript ends can be selected for sequencing using specific amplification primers (optional). For most 
applications, paired-end sequencing is required. (3) The sequencing reads are demultiplexed on the basis of cell-
specific barcodes and mapped to the respective reference genome. UMI sequences are used for the digital 
counting of RNA molecules and for correction of amplification biases. The resulting gene- expression 
quantification matrix can subsequently be normalized, and missing values imputed, before informative genes are 
extracted for the analysis. (4) Dimensional-reduction representations guide the estimation of sample 
heterogeneity and the data interpretation. Data analysis can then be tailored to the underlying dataset, which 
allows cells to be clustered into potential cell types and states, or ordered along a predicted trajectory in 
pseudotime. Eventually, the spatial cellular organization can be reconstructed through the interrogation of 
marker genes (experimentally) or through marker-guided computational reconstruction (inference). PC, principal 
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component. Adapted by permission from Springer Nature: Tutorial: guidelines for the experimental design of 
single-cell RNA sequencing studies, Lafzi, A. et al., 2018. Nature protocols, 13(12) 
2.4 COMPUTATIONAL ANALYSES OF SINGLE-CELL RNA-SEQUENCING 
With the expansion of scRNA-seq, the demand for suitable computational techniques for 
processing, analyzing and interpreting the data has intensified. This has culminated into the 
development of several algorithms and tools addressing the specific analytical and technical 
challenges in the single cell gene expression domain (Stegle et al. 2015; Wagner et al. 2016; 
Zappia et al. 2018). Currently, the “scRNA-tools” database has 393 applications enlisted 
(https://www.scrna-tools.org/) and these are addressing 32 different functional categories 
namely allele specific analysis, clustering, cell cycle, normalization, imputation and 
visualization among others (see figure 3). It is noteworthy that a substantial number of the 
tools were classified in two or more categories. For instance Scanpy, a python-based scalable 
toolkit (Wolf et al. 2018) made up of APIs for Quality Control, Normalisation, Gene 
Filtering, Clustering, Ordering, Differential Expression, Variable Genes, Dimensionality 
Reduction, Visualisation and Simulation. Seurat (Satija et al. 2015; Butler et al. 2018) also 
provides access to single cell analysis tools with similar functions as Scanpy within the R 
platform. These suites provide convenience and enhance efficiency in scRNA-seq data 
analysis by serving as ‘one-stop shop’ for the relevant tools and also reducing the tedious 
exercise of formatting data to be compatible with the different applications in the workflow.  
               
 
           Figure 3: Statistics of tools from scRNA-tools database  
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Quality control assessment and gene expression quantification 
It is common practice to pool several scRNA-seq libraries for sequencing, hence the very first 
analysis step is to demultiplex the resulting reads into respective samples based on their cell-
specific molecular indexes. Illumina’s bcl2fastq tool can demultiplex samples using the user 
provided sample indices in addition to converting the base call BCL files into the fastq 
format. However, with sufficient computational skills, bioinformaticians/analysts can code 
scripts to accomplish sample demultiplexing on unix-based platforms or other programming 
languages.  For the UMI-based methods, identical UMIs are further collapsed into their 
unique tags to gain the absolute counts of the transcripts. Here tools such as: CEL-seq2, Cell 
Ranger, Drop-seq tools, zUMIs and UMI-tools have been used (Hashimshony et al. 2016; 
Zheng et al. 2017; Macosko et al. 2015; Parekh et al. 2018; Smith et al. 2017). These tools 
differ in their methods for determining identical barcodes, the scRNA-seq protocols and 
mapper compatibility among others (Parekh et al. 2018) and some provide additional 
preliminary quality evaluation functions. For instance, zUMIs provides read distributions, 
read downsampling, sample variation, number of genes detected, and is compatible with a 
large number of the scRNA-seq protocolsb(Parekh et al. 2018). For droplet-based techniques, 
the challenge of doublets is significant, hence different approaches have been implemented to 
alleviate this problem. While demuxlet (Kang et al. 2018) uses SNP genotype information to 
predict doublets, DoubletFinder (McGinnis et al. 2019) uses an average transcriptome 
created from single cell expression pairs and Scrublet (Wolock et al. 2019) simulates 
multiplets from the input expression data and uses nearest neighbour classification.   
Next, reads are mapped to a reference genome or transcriptome sequence for gene 
quantification. Aligners have to tackle the challenge of efficiently mapping large number of 
short reads while addressing the potential errors from sequencing. Here short-read, splice 
aware aligners have been most popular for RNA-seq (Garber et al. 2011; Baruzzo et al. 
2017). Most of these were initially developed for processing bulk-RNA-seq data but have 
subsequently been adopted in scRNA-seq analysis. The applications adopt an efficient data 
structure for efficient searches and a divide and conquer strategy to enable efficient memory 
use. These aligners differ in terms of memory requirements, speed and accuracy among other 
metrics and benchmarking studies have been done (Baruzzo et al. 2017). Two of the most 
commonly used aligners are STAR (Dobin et al. 2013) and HISAT (Kim et al. 2015) both 
have implemented a two-pass strategy to allow for improved alignment of reads with short 
anchor fragments across splice junctions. The former uses suffix arrays to match reads to the 
indexed reference and is one of the fastest mappers (Baruzzo et al. 2017) though requires 
large RAM. For less memory intensive mapping HISAT, which uses a novel approach based 
on Burrows-Wheeler Index and FM indexing, would be a better option. The emergence of 
pseudo aligners such as Salmon (Patro et al. 2017) and Kallisto (Bray et al. 2016) capable of 
gene quantification without explicitly mapping reads may improve efficiency in addressing 
single cell questions involving thousands and even million of cells that may not need 
exhaustive expression measurements such as subtype discovery. For the end counting 
protocols with UMIs it is important to remove the barcodes before aligning the reads. 
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The long reads from the non-clonal amplification NGS platforms pose unique challenge 
hence the emergence of various approaches to tackle this (Chaisson & Tesler 2012; Li 2018). 
Additionally, memory efficient algorithm that can be executed on mobile devices for 
handling ONT data has been developed (Gamaarachchi et al. 2019). This makes it suitable 
for the remote settings that lack memory efficient computing platforms.  Once mapping is 
complete gene/transcript quantification is carried out using features counting tools such as 
HTseq-counts (Pyl et al. 2014) to generate an expression matrix. For the end counting 
protocols with UMI-barcoded oligos, counts are derived from number of unique UMI 
barcodes mapped towards a gene but caution must be observed to prevent ghost UMIs 
resulting from PCR or sequencing error and barcode collisions (Islam et al., 2014). 
Quality control (QC) assessment of scRNA-seq data forms the foundation for generating 
accurate results from experiments hence several metrics must be evaluated to ensure data 
quality. These include total number of reads, library duplication rate and complexity, reads 
mapping rates (uniquely mapped, multimaps, ratio of exon to intergenic mapped reads), 
contaminations from non-target organisms and number of detected genes. Some of the QC 
analysis tools are FastQC (Andrews 2016) and Kraken (Davis et al. 2013). In experimental 
designs in which samples have RNA controls the ratio of reads mapped to endogenous genes 
and spike-ins can be an informative metric for library quality i.e. low quality cells tend to 
have lower ratio. Additionally spike-ins may be useful for estimating the RNA starting 
amounts per cell. However, this could mislead in instances of small sized and/or low 
transcribing cells where the ratio reflects the biological state. In mammalian cells low 
expression of the core nuclear genes with concomitant high expression of mitochondrial 
genes has been associated with cells undergoing apoptosis and could be a signature of low 
quality libraries. After gene counts have been normalized clustering samples based on their 
correlations distances or using dimensionality reduction methods (e.g. PCA) while overlaying 
categorical meta information (such as batches, number of genes detected) can help uncover 
low quality cells which may stick out as outliers.  
In practice evidence from multiple metrics is often taken into account before discarding the 
low quality cells from downstream analysis and it has been demonstrated that certain quality 
metrics such as number of genes detected and library mapped read have a prominent 
association with the leading principal components (Wagner et al. 2016; Gaublomme et al. 
2015).  
Batch effects are systemic factors usually caused by technical variations in the scRNA-seq 
experimental procedure. However these can also be biological such as the cycling state of 
proliferating cells or variation by the donor in human derived cells. One of the 
recommendations is to adopt balanced design whenever possible in performing scRNA-seq 
experiments. For instance in treatment versus control study, mixed subsets of samples from 
the two categories should be processed together on independent experiments. Once the 
normalized single cell expression has been generated, it common for the samples (cells) to be 
visualized in lower dimensional subspace, using techniques such as PCA, then superimposing 
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meta data so as to detect any systemic patterns that are non-biological. With the aim of 
overcoming the subjective nature of the visualization approach, novel technique referred to as 
kBET (Büttner et al. 2019) uses nearest neighbour classification after singular value 
decomposition to statistically test if a given variable(meta information) has significant batch 
effect. Additionally different computational methods have implemented techniques such as 
linear regression in ComBat (Jaffe et al. 2012), nearest mutual neighbour (Haghverdi et al. 
2018) and canonical correlation analysis in Seurat (Butler et al. 2018). However, this remains 
an active area of research and robust benchmarking analysis may help reveal the strengths 
and weakness of some of these batch correction methods in the context of scRNA-seq.   
Sub-population discovery 
Unbiased discovery of sub-populations is one of the most dominant applications of scRNA-
seq and in well-defined cell lineages, types or states the method is sufficiently robust. 
However in the context of reduced boundaries between subpopulations separating this groups 
may pose a challenge and one of the reasons would be the curse of dimensionality(Kiselev et 
al. 2019). As the number of features (genes) quantified increases the distance between data 
points (cells) becomes smaller resulting in poorly defined groupings. In order to overcome 
this different schemes have been used including: dimensionality reduction techniques, feature 
selection, down sampling strategies and iterative approaches. The common dimensionality 
reduction methods used are principal component analysis (PCA), t-distributed Stochastic 
Neighbour Embedding (tSNE) (van der Maaten & Hinton 2008) and more recently 
UMAP(Becht et al. 2019). There are studies that have combined either of these methods to 
detect subtypes for example in Petropoulos et al (Petropoulos et al. 2016) the cells were 
reduced into lower dimensions based on PCA then projected onto tSNE subspace. The 
methods are normally applied to a subset of genes that may be known drivers of specific 
biological phenotype (Durruthy-Durruthy et al. 2014), highly variable genes or differentially 
expressed genes identified from complementary techniques (e.g. bulk-RNA-seq, in situ RNA 
hybridization). In selecting most variable genes the commonly implemented strategy is to 
model mean-coefficient of variance (CV) dependency using spike-in controls (or even 
endogenous genes) in order to capture the expected variability (Brennecke et al. 2013). Each 
gene may then be tested for statistical significance in variability beyond the technical noise 
(null). For big cells with sufficient amounts of RNA pool-and-split strategy can be adopted in 
modeling technical dropouts (Deng et al. 2014).  
scRNA-seq data is sparse in nature due to the high dropouts. Several approaches have been 
implemented to mitigate their impact. Mixed models have been used to capture the 
distribution resulting from both successfully sequenced transcripts and dropouts (Kharchenko 
et al. 2014). Data imputation and false-negative curves have also been utilized (Wagner et al. 
2016).  
Making sense of scRNA-seq data is complicated due to both technical and biological several 
factors. Transcriptomes complexity, library quality, impact of batch confounders and quantity 
of cells are some of the factors contributing to the challenge. The 
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varies with cells types with certain cells being more challenging to profile and analyze. 
However, with the unrelenting improvement in both experimental and computational 
methods in scRNA-seq fascinating and important biological pursuits are set to be unraveled. 
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3 PROJECT SPECIFIC BACKGROUND 
In this section I will provide the relevant background to all the different studies that form part 
of my thesis.  
3.1 P. FALCIPARUM AND MALARIA 
Malaria 
Malaria poses heavy health and economic burden globally and is still responsible for close to 
half a million deaths annually mostly in children under five years (Ashley et al. 2018; 
Bousema et al. 2014). Encouragingly the past decade has witnessed a steady decline in 
disease prevalence with up to 60% drop in deaths recorded in some endemic countries 
(Feachem & Sabot 2008). This maybe attributed to the complex interplay between biotic 
(such as vector management, use of efficacious drugs and education) and abiotic factors 
though compelling evidence is lacking (Snow et al. 2017). The reduction in disease 
prevalence notwithstanding, numerous challenges still exist including the emergence of 
resistance to anti-malarial drugs (Miller et al. 2013). Hence there is need for innovative 
technologies to enable in-depth understanding of both the disease and its etiological agent. 
This may culminate in the detection of potential targets for therapies and/or vaccines.  
Malaria is caused by Apicomplexans from the genus Plasmodium with five species infecting 
human namely: P. malariae, P. ovale, P. knowlesi, P.  vivax and P. falciparum (Ashley et al. 
2018; Kantele & Jokiranta 2011). Out of these P. falciparum is the most virulent accounting 
for about 90% of malaria-associated mortalities (Murray et al. 2012). 
P. falciparum life cycle is complex and constitutes two main development phases: asexual 
and sexual  that occur in human and anopheline mosquito respectively (Bousema et al., 
2014). The cycle comprises several stages with distinct morphology and cellular functions 
that mediate parasite’s survival in different host niches (see figure 4). While several of these 
have been targets for developing drugs and vaccines (Delves et al. 2012; Todryk & Hill 
2007), the IDC (intra-erythrocyte development) stage, which is also referred to as blood 
phase, is responsible for the clinical symptoms linked to the disease. This 48-hour cycle 
occurring within the host erythrocytes starts when merozoite invades the RBCs (red blood 
cells) followed by three cytological stages namely: ring (early), trophozoite (mid) and 
schizont (late). Each of these is further subdivided into early and late phase that accomplish 
unique cellular function(s) (Bousema et al., 2014). 
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Figure 4: Illustrating P. falciparum life cycle. The female Anopheles mosquito transmits sporozoites of the 
malarial parasite to the human host. After a period of maturation in the liver, merozoites are released into the 
blood; these invade red cells as part of the asexual (erythrocytic) cycle, and the sexual male and female 
gametocytes are generated from the merozoites. During a subsequent blood meal, a mosquito takes gametocytes 
into the midgut, leading to macro (female) and micro (male) gametes, which, after fertilization and zygote 
formation, produce an ookinete that penetrates the mosquito gut wall and generates oocysts containing 
sporozoites. Adapted by permission from Springer Nature: Protective hemoglobinopathies and P. falciparum 
transmission, Pasvol, G., 2010. . Nat Genet, 42(4) 
Gene expression regulation in P. falciparum 
To achieve the remarkably complex life cycle P. falciparum is endowed with a fine-tuned 
gene expression control program. This regulatory program occurs at multiple levels namely: 
epigenetic, transcriptional, post-transcriptional and translation (Painter et al. 2011). Like 
other eukaryotes a coordinated interplay between these multiple levels define the expression 
outcome.  
The genome encodes the basal transcriptional machinery constituting Pol II, general and 
specific transcription factors. However, to date only 27 trans acting factors have been 
annotated and these belong to the plant-like Apatela factors referred to as ApiAP2 factors 
(Painter et al. 2011; Painter et al. 2018). With this limited number of regulatory factors it is 
possible that post-transcriptional and epigenetic may be involved in controlling the 
expression of most genes. Epigenetic regulation directs the mutual exclusive expression of 
the 60-member var gene family that are important for host immune evasion and confer 
parasite virulence (Lopez-Rubio et al. 2009). Heterochromatin marks have been found to 
correlate with the expression of clonally variant gene families located in the sub-telomeric 
regions of chromosomes (Anon 2009). Intriguingly, active epigenetic marks and the 
modifying enzymes have been shown to correlate with the dominant var gene and facilitate 
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clonal variant switching (Freitas-Junior et al. 2005; Lopez-Rubio et al. 2007; Petter et al. 
2011; Volz et al. 2012). Epigenetics also play a role in regulating the other variant gene 
families (rif and stevor) during IDC (Guizetti & Scherf 2013; Kirkman & Deitsch 2012). 
Though not well-studied splicing is believed to contribute to the regulatory framework 
(Horrocks et al. 2009).  
Non-coding RNAs play significant regulatory role in eukaryotes and P. falciparum snRNA, 
snoRNAs, telomerase RNAs and NATs (natural antisense transcripts) have been described 
(Vembar et al. 2014). Adjacently located ncRNAs could be involved in the allelic regulation 
of var genes and NATs are also assumed to have a repressive effect on their corresponding 
genes (Vembar et al. 2014; Siegel et al. 2014). It is worthy to note that several levels of 
regulation can jointly control the expression of gene(s) to achieve a specific phenotype or 
function as evidenced by var genes control. With recent compelling evidence for 
chromosomal organization role in controlling virulence genes (Bunnik et al. 2019) it is 
suffice to infer that we are at the initial stages of understanding how this important parasite 
regulates its transcriptome in various context.        
Transcriptional control of IDC 
IDC is an important development stage with significant implications for the intervention and 
management of the disease. It is responsible for all the clinical symptoms attributed to 
malaria and the target for all effective drugs (Delves et al. 2012). Additionally it forms the 
foundation for a number of vaccine design strategies (Todryk & Hill 2007). Most studies 
reveal that over 90% of the genome is transcribed at this stage (Otto et al. 2010; Painter et al. 
2018). Hence unraveling the underlying gene expression mechanisms provide an opportunity 
to understand parasite’s biology at the transcriptional level.  
IDC ring stage starts after merozoite invasion of erythrocytes during which the parasite 
remodels host’s intracellular environment for its successful establishment. To achieve these 
complex transitions between functionally and morphologically divergent stages while being 
able to mount protective responses against external stress (e.g. host’s immunity, temperature 
changes, drugs, etc) an elaborate molecular regulation program is essential (Bozdech et al. 
2003).  
P. falciparum genome is pervasively transcribed in IDC. This remarkable feat is 
accomplished in spite of the limited number of specific transcriptional factors characterized to 
date. The parasite has evolved an intricate transcription mechanism that has been described as 
a  ‘just-in-time’ or ‘transcripts-to-go’ model in which genes are transcribed almost in an 
instant fashion at the time the proteins they encode are required (Bozdech et al. 2003; Otto et 
al. 2010; Le Roch et al. 2003). For instance, following erythrocyte invasion, ring stages 
express general cytoplasmic transcriptional and translational machinery, and then the 
metabolically active trophozoites express DNA replication and metabolism genes. At 
schizontal stage the parasite undergoes replication and initiate the expression of invasive 
genes in preparation for erythrocytes reinvasion. 
  23 
Gene expression profiling has been key in providing the molecular understanding of IDC. 
The 1 hr time-scale resolution of P. falciparum HB3 strain using microarray technique has 
been the most comprehensive investigation of IDC (Bozdech et al., 2003). The study 
established that at least 60% of the genome is transcribed and most of the genes display 
periodicity in their expression with one minima and maxima peak per cycle. Additionally, it 
uncovered the outstanding cascades of stage-specific gene expression that mirrored the 
corresponding cellular and morphological function(s). This malleable transcriptional 
landscape has been reaffirmed in other studies (Le Roch et al., 2003; Otto et al., 2010) and 
was found to be conserved even in geographically diverse isolates (Rovira-Graells et al. 
2012).  
Understanding gene expression regulation during IDC has been of critical interest and 
currently there is growing evidence for multiple levels of control.  P. falciparum genome 
encodes DNA-binding transcriptional factors with a putative AP2 DNA-binding domain 
which is common in plants transcriptional factors. These factors belong to the Apicomplexan 
AP2 (ApiAP2) protein family (Balaji et al. 2005) and are utilized in the classical cis-trans 
regulation of the core promoter complex during transcription. Most of them are expressed in a 
stage-specific fashion and have varying degree of importance in IDC progression as 
established in knockout experiments (Otto et al., 2010; Painter et al., 2011; 2018). However, 
how they regulate transcription initiation in IDC is still an open research question. 
Post-transcriptional regulation is also crucial during IDC and it encompasses transcript 
maturation (5’-capping, 3’-polyadenylation, splicing, etc) and stability (rate of de novo 
synthesis and degradation) (Horrocks et al. 2009). The mRNA half-life has been established 
to change during IDC with transcript stability increasing from ring to schizont development 
stages (Shock et al. 2007; Sims et al. 2009). However, recent results from nascent 
transcription profiling study failed to support this across numerous genes (Painter et al. 
2018). In regard to splicing, more than half of P. falciparum protein coding genes have 
introns (Gardner et al., 2002) and all the components of splicing machinery have been 
characterized.  Though the exact mechanism of splicing regulation remains elusive, gene 
isoforms have been detected during IDC, which could represent an additional layer of 
regulation. In the study by Sorber et al (Sorber et al. 2011) a total of 405 splicing events were 
detected with majority being alternative 5’- or 3’- splice sites and 254 alternative isoforms. 
These events are speculated to generate truncated proteins or could be involved in fine-tuning 
gene expression profile in IDC. Long non-coding RNAs (lncRNAs) and natural antisense 
transcripts provide an additionally level of post-transcriptional regulation by silencing the 
translation of target transcripts through degradation or translational repression and have also 
been established to regulate IDC gene expression (Vembar et al. 2014). 
Single cell transcriptomics in malaria 
While scRNA-seq technique was becoming mainstream and impacting several domains in 
mammals and man it was not until 2017 that initial studies profiling P. falciparum at cellular 
resolution were published (Poran et al., 2017). Since then another single cell expression study 
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looking mainly at sexual differentiation in P. falciparum has been carried out (Reid et al., 
2018). However the application of scRNA-seq still lags far behind in comparison to 
mammalian or model organisms. This is attributable to the technical difficulties such as the 
tiny sized parasites with low amounts of RNA, extreme AT richness yielding low complexity 
libraries and dearth in scRNA-seq protocols optimized to process this parasite among others 
(Gardner et al. 2002; Nair et al. 2014; Reid et al. 2018). These challenges notwithstanding, 
scRNA-seq still holds immense promise in advancing several aspects of malaria biology 
including sexual development. 
IDC development and sexual commitment have been the only studied aspect of the parasite 
using scRNA-seq methods. So far only lab-adapted isolates sampled at broad range of 
timepoints have been investigated. It is conceivable that scRNA-seq targeting shorter 
resolution times with improved number of detected genes may enhance the transcriptional 
resolution of both IDC and sexual commitment. In the Poran et al study where wild type 
isolates were profiled the use of less sensitive Drop-seq platform may have restricted the 
resolved sub-populations (Poran et al., 2017).  
scRNA-seq profiling of field isolates from patients without or with minimal lab-adaptation 
may provide holistic insights into the disease pathogenesis and the impact of host immune 
system even though the logistics and technical challenges would be immense. Using in vivo 
murine malaria models for such studies may also provide complementary results. 
Additionally, the regulation of clonally variant gene expression (Reid, 2015), infected RBCs 
binding phenotypes (Goel et al. 2014; Miller et al. 2013) and drug resistance (Artemova et 
al. 2015) are some of the aspects of the disease that scRNA-seq may impact. For instance 
rosetting has been established to occur in a blood type dependent manner (Goel et al. 2014). 
Using single-cell methods it would be possible to at least delineate the transcriptional 
mechanisms underlying such a significant pathophenotype.  
The application of scRNA-seq to understanding the blood stage and even the other stages is 
in its early phases. With improved designs mirroring the disease, enhanced scRNA-seq 
protocols and complimentary technologies the regulation of key genes will be unraveled and 
these may become potential targets for drug/vaccine development. 
3.2 COMPARATIVE ANALYSES OF SINGLE-CELL RNA-SEQUENCING 
METHODS 
In most studies aimed at characterizing sub-population(s) at cellular resolution, a specific 
scRNA-seq protocol is used for library generation proceeded by multiple computational steps 
culminating in unsupervised detection of distinct cell clusters. Presently alternatives exist for 
protocols, normalization, genes (features) selection, dimensionality reduction and clustering 
hence posing a critical challenge when designing such studies. This has invigorated the need 
to benchmark their performance. 
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scRNA-seq protocols benchmarking  
Several protocols for generating scRNA-seq libraries for sequencing exist. These differ in 
their chemistries, implementation platforms and performance. To this end several 
benchmarking attempts have been carried out (Bagnoli et al. 2018; Sasagawa et al. 2013; 
Sheng et al. 2017; Svensson et al. 2017; Wu et al. 2014; Ziegenhain et al. 2017). 
These comparisons often evaluate the protocols in terms of their number of detected genes 
per cell (sensitivity), cells throughput, precision (variability in gene expression measurement 
between replicates), accuracy (based on comparison with other expression profiling methods 
e.g. single-cell multiplex qPCR), cost, transcript coverage and library complexity. While end 
counting methods have been attractive for their ability to mitigate amplification bias by using 
UMIs these may underestimate the expression of endogenous genes (Svensson et al., 2017). 
Small variations in the implementation of a given protocol give different performance results 
e.g. CEL-seq2 on Fluidigm C1 and microwell-plate results in poor sensitivity (Svensson et al. 
2017). In numerous protocols newer versions with optimizations from the initial method have 
been established (Hashimshony et al. 2012; Hashimshony et al. 2016; Soumillon et al. 2014; 
Bagnoli et al. 2018). Until recently most benchmarking studies utilized cell lines or spike-in 
controls to compare protocols. However a new study evaluating three main commercial 
platforms (10X genomics, Drop-seq and inDrop) used human pancreatic islet cells hence 
making it possible to compare their potential to recapitulate known distinct cell constituents 
(X. Zhang et al. 2019). 
Clustering methods comparison 
Unsupervised clustering is fundamental in the characterization and/or discovery of sub-
populations of cells belonging to distinct cell type or state. At the time of writing 115 tools 
were listed in the clustering category in the online database (Zappia et al., 2018). While 
several specialized algorithms have been developed to tackle the idiosyncrasies of scRNA-
seq data, the use of conventional clustering methods such as K-means , hierarchical  and 
graph-based one (Pijuan-Sala et al. 2019) has continued. It is noteworthy that some of the 
prevailing methods are modification of pre-existing clustering techniques for instance SIMLR 
(Wang et al. 2017) and RaceID (Grün et al. 2015) have optimized k-means for tackling the 
problem of rare cell type detection. CIDR (Lin et al. 2017) modifies hierarchical approach for 
single cell data.  
There are several metrics used for estimating the distance between clusters including 
Euclidean, cosine and correlation. The latter two are scale independent making them robust to 
the high variation in gene expression measurements (Kiselev et al. 2019). In terms of 
performance evaluation it has been established that the distance metric and protocol choice 
influence clusters discovery (Kim et al. 2018). 
Bi-clustering technique, BackSPIN, has been useful in determining sub-clusters of cells with 
distinct signatures of expression (Zeisel et al. 2015). 
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Different clustering methods have their merits and demerits (Kiselev et al., 2019). Hence 
methods such as SC3 have adopted a consensus-based strategy to facilitate the identification 
of robust groupings (Kiselev et al. 2017). 
Normalization comparison 
Normalization is a critical step in making sense of scRNA-seq data since it seeks to remove 
unwanted technical and/or biological variation from the digital expression measurements. A 
number of methods exist each addressing different aspect of scRNA-seq e.g. zero-inflation (L 
Lun et al. 2016), technical variance (Yip et al. 2017) and sequencing fluctuations between 
cells (Bacher et al. 2017; Wolf et al. 2018). Methods such as BASiCs (Vallejos et al. 2017) 
and DESEq2-sc (Brennecke et al., 2013) require exogenous spike-ins to model the technical 
variation. It is noteworthy that there are scRNA-seq studies that have adopted normalization 
schemes earlier used for bulk-RNAseq (such as TMM (Robinson & Oshlack 2010), DESeq2 
(Love et al. 2014) and RPKM (Mortazavi et al. 2008).  
Log-transformation of the normalized gene expression matrix is common practice and usually 
a pseudo value is added to preclude undefined values from non-detected genes. 
Using unsuitable methods may lead to erroneous outcomes in the downstream analysis such 
as highly variable and differential gene expression detection (Vallejos et al., 2017) resulting 
into incorrect conclusions. While there are earlier studies that showed scRNAseq-tailored 
methods (scran and BASiCs) outperforming bulk ones in generating accurate scaling factors 
(Vallejos et al., 2017) an exhaustive assessment is still lacking.  
Dimensionality reduction and feature selection 
Processing scRNA-seq data results in high dimensional expression matrix that comprises 10s 
to 1000s of cells and several thousands of genes. In order to reduce this complexity while 
retaining the biological signal several strategies are involved. Instead of using all detected 
genes one may opt for differentially expressed genes between sub-groups, highly variable 
genes (HVGs) or key markers if the biological process is well characterized. The use of 
HVGs is widely adopted especially in the context of unsupervised discovery of sub-
populations. To determine HVGs the frequently adopted approach entails modeling mean-CV 
(coefficient of variation) relationship and determining candidates with variation above the 
null. Varied cut-offs for top HVGs have been utilized: 100 (Posfai et al. 2017), 2000 
(Wagner et al. 2018), 3000 (Cadwell et al. 2016), 5000 and even more (Giustacchini et al. 
2017; Zeisel et al. 2015). The appropriate cut-off largely depends on the biological question 
and the variability within the data. 
After feature selection the cells may be projected onto lower dimensions using specialized 
techniques that maybe linear or non-linear (Becht et al. 2019; Woodhouse et al. 2015). Here 
the common methods are: Correlation (Pearson or Spearman), PCA, tSNE (van der Maaten 
& Hinton 2008) and UMAP (Becht et al. 2019).  
  27 
Simulation approaches  
Several studies looking into the performance of scRNAseq have adopted various simulation 
strategies (Zappia et al. 2017; Vieth et al. 2017). It is noteworthy that these studies have been 
applied in the context of distinct cell states/types or were simulated using parametric models 
that may not reflect the complete complexity of scRNA-seq data. Furthermore in certain 
instances spike-in controls have been used to evaluate the impact of scRNA-seq protocols 
(Svensson et al. 2017) and clustering metrics on subtype discovery (Kim et al. 2018). Hence 
the need for accurate simulation of subtypes, unbiased comparisons and comprehensive 
assessment of different parameters in the context of subtle differences between sub-
populations remains to be explored. 
3.3 EPITHELIAL-TO-MESENCHYMAL TRANSITION 
Cancer is a leading cause of death globally and approximately 90% of the mortalities are 
attributed to the metastatic spread of malignant tissues from the primary site to vital 
secondary organs (Hanahan & Weinberg 2000; Hanahan & Weinberg 2011). Compelling 
evidence implicates EMT (epithelial-to-mesenchymal transition) in cancer metastasis 
(Lawson et al. 2015; Pastushenko et al. 2018). EMT entails the switching of an epithelial 
cell to mesenchymal state and the reversal process is known as mesenchymal-to-epithelial 
transition (named MET). First described in the 80s, EMT and MET (simply abbreviated 
EMT-MET) have been established to be critical in gastrulation and neural crest migration 
during embryonic development, the formation of septa and valve in heart development and 
post-embryonic tissue maintenance in human and other mammalian systems (Thiery, 
Acloque, Huang & Nieto 2009a; Gonzalez & Medici 2014). However in disease, EMT-
MET program are reactivated leading to pathogenic progression of conditions such as tissue 
fibrosis and malignant cancer (Thiery, Acloque, Huang & Nieto 2009b). In light of the 
significant health implications of EMT-MET, understanding the mechanism(s) is critical goal 
in cancer biology. 
Molecular biology of EMT 
EMT-MET are complex and transitory processes that transform the sessile carcinoma cells 
into invasive and migratory mesenchymal state. During the process concurrent conferment of 
anti-apoptic, anti-therapeutic and stem-like competences occur (Lawson et al. 2015). It is 
regulated at different levels namely: epigenetic, transcriptional and post-transcriptional 
(Lamouille et al. 2014; L. Li & W. Li 2015). These divergent regulatory mechanisms 
operate in an integrated fashion leading to the activation of genes that are important in 
inducing and maintaining EMT. A number of these genes and signaling pathways have been 
described based on in vivo and in vitro models.  
To accomplish these remarkable changes malignant carcinomas, in response to extracellular 
stimuli from tumor microenvironment, transduce an intracellular signaling cascade that 
culminates into the activation of core EMT transcriptional factors (core EMT-TFs) (Nieto et 
al. 2016; De Craene & Berx 2013; Shibue & Weinberg 2017). The core EMT-TFs directly 
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or indirectly repress the transcription of key epithelial phenotype maintenance genes and 
activate mesenchymal ones. The generated tumorigenic mesenchymal cells can be 
disseminated to secondary/distal organs via the vascular system and through the reverse MET 
process result in metastatic malignancy. This has been referred to as the classical view of 
EMT-MET. It encompasses two major states (epithelial and mesenchymal), its regulation is 
principally driven at the transcriptional level and its basis relies on in vitro experimental 
models. 
Over the years with improved molecular phenotyping technologies and robust in vivo cancer 
models alternative views of EMT-MET are emerging. Growing evidence suggest that the 
process is highly plastic encompassing several intermediate and reversible states between the 
epithelial and mesenchymal spectrum (Pastushenko et al. 2018; Lawson et al. 2018). In 
terms of regulation, non-transcriptional mechanisms may play a significant role in the 
transitory process and different EMT programs can be utilized by malignant neoplasms 
depending on tumor subtypes, tissues affected, cell states or types and the microenvironment 
(Lamouille et al. 2014). These novel discoveries have intensified the need to define and 
refine the potential intermediate states during EMT, establish all the regulatory mechanisms 
governing EMT-MET and describe the different EMT-MET programs employed by distinct 
cancer types during metastasis. To this end single-cell technologies in combination with 
robust in vivo cancer models have been began generating invaluable molecular understanding 
of EMT-MET (Pastushenko et al. 2018; Lawson et al. 2018). These studies hold immense 
promise in tackling metastasis with the ultimate goal of inspiring innovative therapies for 
managing malignant cancer. 
During EMT the strong epithelial cell-cell junctions have to be broken down and several 
genes encoding these junctional proteins are down regulated. This leads to cells with an 
enhanced migratory phenotype and higher affinity for mesechymal cells (Wheelock et al. 
2008; Yilmaz & Christofori 2009a). To accomplish this E-cadherin (CDH1) gene, is down 
regulated and the loosely binding N-cadherin (CDH2) gene is up regulated.  This switch from 
CDH1 to CDH2 is an established hallmark of EMT (Lamouille et al. 2014). Epithelial cells 
loose their apical-basal polarity during EMT and this is facilitated by the down-regulation of 
polarity complex genes and enhanced by the interruption of their interactions with the 
junctional proteins (Moreno-Bueno et al. 2008). Cytoskeleton modification occurs during 
EMT and this is facilitated by the down-regulation of cytokeratin encoding genes and up-
regulation of vimentin (Huang et al. 2012). To modulate the interactions of epithelial cells 
with the extracellular matrix the expression of integrin encoding genes also change during 
EMT (Yilmaz & Christofori 2009b).  
Key transcription factors (TFs) regulating EMT are the zinc-finger binding TFs (Snail1 and 
Snail2) and the basic-helix-loop-helix binding proteins (Twist, zinc finger E-box-binding 
homeobox 1(ZEB1) and ZEB2) (Gonzalez & Medici 2014). They operate synergistically by 
binding the promoter regions of genes that may activate mesenchymal state or deactivate 
epithelial phenotypes in EMT. For instance, Snail1 binds to the promoter region of CDH1, 
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the gene encoding E-cadherin, leading to its repression (Batlle et al. 2000; Cano et al. 2000) 
and its accumulation in the nucleus has been associated with metastasis in breast cancer 
(Yook et al. 2006).  There are additional TFs that work in unison with the master regulators 
to achieve more specific functions in EMT. A comprehensive account of the transcriptional 
regulators and gene expression changes in EMT have been reviewed by Lamouille et al 
(Lamouille et al. 2014). 
Post-transcriptional regulation by pre-mRNA splicing and microRNA-mediated degradation 
is established in EMT. Splicing is mainly driven by the down-regulation of ESRP1 (epithelial 
splicing regulatory protein) and ESRP2 resulting in isoforms that enhance mesechymal 
phenotype (motility, loose adhesion, signaling pathways) (Warzecha et al. 2010). 
Additionally, the expression regulation of RBFOX2 (RNA binding protein FOX1 homologue 
2) and SRSF1 (Ser-Arg-rich splicing factor 1) facilitate splicing alterations in EMT 
(Braeutigam et al. 2013; Valacca et al. 2010). Example genes that undergo alternative 
splicing include p120 catenin, CD44 (adhesion protein cluster of differentiation 44), among 
others.   
Non-coding microRNAs (miRNAs) block the translation of specific RNA transcripts by 
targeting them for degradation or inhibiting their translation. Several miRNAs have been 
characterized as regulators of EMT with some binding EMT master TFs (Lamouille et al. 
2013). For instance, miR-29b (Ru et al. 2012) and miR-30a (J. Zhang et al. 2012) repress 
EMT by binding Snail1. Other EMT genes that are miRNA targets include E-cadherin, N-
cadherin, PAR3, among others (Lamouille et al. 2014).  
For successful metastases, an epithelial tumor-initiating cell needs to undergo de-
differentiation into a migratory mesechnymal cell and subsequently re-differentiation into an 
epithelial state. This process requires some reversible reprogramming mechanism and several 
epigenetic modifications have been established to drive this transient process (Tam & 
Weinberg 2013). 
Cell signaling in EMT 
Cell signaling pathways are key in EMT since they activate the expression of EMT-inducing 
transcription factors via a cascade of intracellular kinases(Gonzalez & Medici 2014; 
Lamouille et al. 2014). The EMT-inducing signaling pathways include the ones mediated by 
TGF-β (transforming growth factor - beta), FGF (fibroblast growth factor), EGF (epidermal 
growth factor), BMP (bone morphogenetic protein), Wnt, Shh (Sonic hedge hog), Notch, 
PDGF (platelate-derived growth factor) and integrin.  These pathways may act predominantly 
at specific stages of EMT and in a cell type dependent manner (Lamouille et al. 2013).  
TGF-β pathway, the most well characterized signaling in EMT, is activated by the TGF-β 
superfamily ligands with TGF-β1, BMP2 and BMP4 known to induce the process in cancer 
(Gonzalez & Medici 2014).  It evokes EMT in a cascade of intracellular interactions that 
generate SMAD complexes that combine with DNA-binding TFs at regulatory elements to 
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control transcription (Lamouille et al. 2013; Lamouille et al. 2014).  For instance Snail1 
expression is induced through TGFβ-mediated activation of SMAD3 and both SMAD3 and 
SMAD4 regulate the expression of HMGA2 (high mobility group A2) in TGFβ-induced 
EMT (Lamouille et al. 2013). However, it is worthy to note that there are TGFβ-induced 
EMT pathways that do not bind EMT-TFs directly but instead activate the expression of 
mesenchymal genes during EMT through active SMADs.  Additionally, TGFβ induces EMT 
by complimentary non-SMAD signaling cascades such as RHO-like GTPases, ERK MAPK 
and PI3K (Lamouille et al. 2013).   
The EMT-inducing signaling pathways often interact and cooperate with each other to 
activate or repress EMT progression. For instance TGFβ-induced EMT cause adherens 
destabilization leading to β-catenin accumulation in the nucleus that feed into Wnt signaling. 
For a comprehensive description of the key EMT signaling pathways the review by Gonzalez 
et al (Gonzalez & Medici 2014) is recommended.  
EMT and single cell gene expression profiling 
In malignancies single cell profiling can be useful in enhancing cancer biology (Tirosh, Izar, 
et al. 2016; Tirosh, Venteicher, et al. 2016) and addressing multiple aspects including 
prognosis (Dalerba et al., 2011). Tackling the transcriptional basis of EMT at cellular 
resolution has burgeoned over recent years. Based on PDX models of breast cancer 
metastasis 116 genes were profiled using FACS sorting in combination with Fluidigm’s 
multplex qPCR (Lawson et al., 2015). These genes are involved in EMT, stemness, 
proliferation, cycling and lineage specification. The study established that there was distinct 
signature between low and high burden metastasis with the former expressing key stem cell 
maintenance (Sox2, Oct4/Pouf5), EMT programme (Nai2, Skp2 and Twist1) and dormancy 
genes (Cdkn1b, Chek1, Tgfbr3 and Tgfb2). Low-burden metastases were more prolific in 
singly seeding tumors than high-burden derived xenografts. Differentiation status correlates 
with metastatic burden with the low burden metastasis expressing basal/stem-like signature 
while high burden having a more luminal expression signature both at transcriptional and 
protein level (Lawson et al., 2015).  
The first in vivo model of skin squamus cell carcinoma (SSC) based on genetically 
engineered mice established the existence of partial-EMT sub-populations using single-cell 
approach (Pastushenko et al., 2018). The model is mediated by the conditional and targeted 
expression of the oncogene, KRas, and repression of tumor suppressor gene p53 in hair 
follicles.  
With increasing adoption of scRNA-seq techniques in EMT-MET studies and improved 
models a refined molecular understanding of this complex process may be achieved in the 
coming decade.  
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3.4 MYELODYSPLATIC SYNDROME AND CANCER STEM 
Myelodysplastic syndrome (MDS) is a collection of clonal hematopoietic disorders 
characterized by abnormal blood cells morphology in one or more lineages (dysplasia), 
defective hematopoiesis leading to low blood counts (cytopenia) and a predisposition to 
secondary acute myeloid leukemia (Sperling et al. 2017). It is the most prevalent 
hematopoietic malignancy with 5.3 to 13.1 cases per 100,000 individuals reported in United 
States. Due to the difficulty in diagnosing MDS and limited records of incidence, it is 
suspected that the incidence could be higher than current estimates (Özcan, Ilhan, Ozcebe, 
Nalcaci & Gülbas 2013a; Sperling et al. 2017). Overall, every indication from the 
inadequate data is that MDS incidences are increasing which has been attributed to the aging 
population, rise in therapy-related MDS and enhanced awareness. Currently three United 
States FDA approved agents for treatment (azacitidine, decitabine, and lenalidomide) but 
only allogeneic bone marrow transplant has curative capacity (DeZern 2018). 
Molecular and genetic basis of MDS 
Several chromosomal aberrations have been detected in distinct MDS subgroups (Özcan, 
Ilhan, Ozcebe, Nalcaci & Gülbas 2013b; Sperling et al. 2017). These include interstitial 
deletion of chromosome 5 long arm (del 5q-MDS), trisomy 8, monosomy 7 and 17p 
syndrome among others.  Joint operation between initiating and cooperative mutations in 
hematopoietic stem cells or progenitors establishes clonal dominance that progresses to MDS 
and in some cases culminates into secondary AML (Sperling et al. 2017). This involves the 
interplay of epigenetic alteration, stepwise acquisition of cooperative mutations and bone 
marrow microenvironment. The initial foundational mutations generate clonal hematopoiesis 
which then acquire cooperative mutations that drive the progression to MDS and ultimately 
sAML.  Some of the commonly mutated genes in MDS are categorized as epigenetic (e.g. 
DNMT3A, TET2), splicing genes (e.g. SF3B1, SRSF2, U2AF1) and transcription factors (e.g. 
RUNX1 CUX1).  
Cancer stem cell theory and myelodysplastic syndrome 
Intra-tumoral heterogeneity facilitates distinct cell types/states in malignancies and some of 
these sub-populations may confer fitness such as anti-therapeutic response in malignancies 
(Lawson et al. 2018). Cancer stem cells (CSC) concept from the 1960s posits a 
heterogeneous and hierarchical organization of malignant tumors in a stem cell-like 
configuration that mirrors the corresponding non-neoplastic tissue. In this organization the 
small sub-population of distinct CSCs, with self-renewal and multi-lineage differentiation 
capability, maintain the tumor tissue by repopulating the non-tumorigenic cancer cells 
through differentiation while retaining the reservoir of CSCs (Kreso & Dick 2014). This 
phenomenon was initially proven in the hematopoietic malignancy, Acute Myeloid Leukemia 
(Bonnet & Dick 1997) in mouse-models and later in solid tumors (Al-Hajj et al. 2003). The 
CSC were shown to have a distinct immunophenotype and long-term tumor initiating 
potential in in vivo xenografts (Jones & Armstrong 2008).  Since then CSCs have been 
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identified in various cancers including brain, lung, head and neck, and colon (Kreso & Dick 
2014). In some cancers it has been proven that the CSC state is dynamic such that non-
tumorigenic sub-populations may gain tumor initiating potential and vice-versa. This is 
mediated by genetic, non-genetic (such as epigenetic modification) and context-dependent 
mechanisms (Kreso & Dick 2014).  
Given the clinical significance CSCs there is greater need to understand their biology in 
depth. For instance in del5q MDS patients a distinct sub-population of multi-potent stem cells 
(CD34+CD38-CD90+Lin-) was shown to confer lenalidomide resistance and had potential to 
reconstitute myeloid progenitors in in vitro long-term colony assays (Tehranchi et al. 2010; 
Woll et al. 2014). In AML transcriptional signature of tumorigenic sub-population was 
linked to patients prognosis (Eppert et al. 2011). Therefore with improved models and 
enhanced techniques (e.g. use of microRNA and reporter assays) the characterization and 
molecular validation of CSCs is set to enhance our knowledge in cancer biology.  
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4 AIMS 
In this thesis, I used scRNA-seq to tackle key biological problems in infectious disease and 
cancer as well as performed computational assessment of the general possibilities and 
limitations of scRNA-seq for enumerating cell types and states de novo.  
4.1 PAPER I 
• Establish and optimize a workflow for isolating and preparing scRNA-seq libraries from P. 
falciparum intra-erythrocytic development cycle (IDC) stages. 
• Analyze the heterogeneity and describe sub-populations of P. falciparum during IDC 
development at cellular resolution based on scRNA-seq. 
• Identify novel and known markers involved in IDC and sexual differentiation at single cell 
level. 
4.2 PAPER II 
• Establish a computational workflow for simulating and discovering sub-populations of 
cells from pre-existing homogenous scRNA-seq data. 
• Define the limits of subtype discovery and the impact of seven parameters in the 
computational workflow for sub-population discovery, and across scRNA-seq protocols.   
4.3 PAPER III 
• Investigate the impact of TGF-ß1 induced EMT (epithelial-to-mesenchymal transition) on 
lung metastasis colonization and growth. 
• Monitor how TGB-ß1 induced EMT affected long-term molecular programs during 
metastatic cancer growth in the lung. 
4.4 PAPER IV 
• The generation and computational analysis of gene expression profiles of MDS stem cells 
and hematopoeitic progenitors. 
• Determine the transcriptional signature in relation to specific genetic abberations in MDS 
stem cells, in comparison to hematopoietic progenitors. 
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5 RESULTS AND DISCUSSION 
5.1 PAPER I 
Malaria is an important infectious disease with the most severe form caused by Plasmodium 
falciparum. During infection there are several phenotypes of the disease that occur in a 
limited subset of the infected erythrocytes such as cytoadhesion, drug resistance and sexual 
commitment among others. These often have significant implications for the disease 
virulence and transmission. For instance, sexual differentiation generates a reservoir of 
metabolically inactive gametocytes that can be taken up by the female anopheline mosquito 
and further transmitted to human host. While the genetic basis and mechanisms responsible 
for some of these phenotypes have been unraveled an exhaustive molecular understanding is 
lacking partly due to shortage of high throughput and sensitive technologies that can resolve 
these rare phenotypes at a single cell level.  
Hence in this study we applied scRNA-seq to the intra-erythrocyte development (IDC) stage 
of P. falciparum both as a proof-of-principle and to assess if it is possible to study sexual 
differentiation at cellular resolution. It is noteworthy that while scRNA-seq technologies had 
begun impacting various domains in biology in 2009 and earlier in the decade (Xue et al. 
2013; Deng et al. 2014; Jaitin et al. 2014; Fan et al. 2015; Patel et al. 2014), this technology 
remained unexplored in malaria. In this study, we demonstrated that scRNA-seq could 
capture the distinct states of the parasite during IDC as evidenced by the correlation between 
aggregated single cell expression and bulk controls per IDC sub-stage and the expression of 
IDC regulated genes. The average number of genes we detected per cell in our dataset was 
comparable to the Reid et al dataset (Reid et al. 2018 data and higher than Poran et al (Poran 
et al. 2017). The Reid et al study further optimized the application of Smart-seq2 for parasite 
profiling and they also implemented strategies to filter rRNAs, which may explain their 
detection of higher numbers of genes. It is noteworthy that these two studies only profiled 
late trophozoite, schizont and gametocyte stages but we additionally sampled earlier 
timepoints. The number of detected genes per sample increased with the sampling time. This 
corroborates the findings that ring stages tend to have lowest transcriptional activity in 
comparison to the other IDC stages and mRNA half-life increases with the IDC progression 
(Shock et al. 2007; Sims et al. 2009). However, the drop in number of genes in T3 timepoint 
cells (likely early trophozoite) was unexpected. This pattern may reflect a sub-state in the 
developmental trajectory since it was observed in all independent experiments targeting this 
stage. While earlier ensemble-based expression profiling had revealed cascades of 
transcriptional changes during IDC (Bozdech et al. 2015; Le Roch et al. 2003; Otto et al. 
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2010) here we observe discrete expression signatures within the eight subpopulations that we 
established. The cascades at bulk level maybe an indication of the gradual transitions down 
the IDC development at unsynchronized rate by the parasites.  
On the host side we detected a number of remnant human mRNA transcripts including HBA2, 
HBB, HBD, SAT1 NKX3-1 and others. These are likely leftovers of initially transcribed genes 
during erythropoiesis before enucleation and maturation of the terminally differentiated 
erythrocytes.  
Intriguingly, we illuminated a subset of sexually differentiated P. falciparum that had a 
defined gene signature of ten novel genes, five of which were validated to have higher 
expression in populations of gametocyte-enriched parasites. These 10 genes could separate 
sexual and asexual parasites in Reid et al data (Reid et al. 2018) and had been detected in 
independent datasets accessible in PlasmoDB database (Aurrecoechea et al. 2009). These 
candidate markers of sexual commitment may denote important genes for parasite 
transmission that could be exploited for the design of transmission-blocking drugs and/or 
vaccines. However the fact that all the ten are annotated as hypothetical proteins is limiting 
and is illustrative of the large numbers of P. falciparum genes that still lack biological 
functional annotation. The two candidates Pf3D7_1474000 and Pf3D7_0205100 are most 
intriguing since further evidence from independent transcriptome and proteome profiling 
experiments deposited in PlasmoDB database (Aurrecoechea et al. 2009) also shows their 
gametocyte specificity and critical role in the parasites survival.  
Mutually exclusive expression of gene families is a hallmark of P. falciparum survival within 
host. Here we profiled the var and clag genes that are involved in cytoadhesion and 
erythrocyte invasion respectively. We confirm dominant expression of clag3.1 and clag3.2 in 
a subset of the SCTs with co-expression of the two genes in a few of the cells. We confirm 
the dominant expression of var genes: Upsc1, Upsb1 and Upse in subet of cells. The latter is 
the pregnancy-associated var2csa antigen that facilitates iRBCs adhesion to the uterine 
membrane. 
After sequencing and aligning the read fragments, we utilized multiple metrics of quality 
control including detection of outliers based on correlation distance between samples and 
PCA and tSNE projections, mapping rates of reads and the qualities of base calls from 
sequencing. Most informative was to require at least 10,000 uniquely mapped reads per cell 
and the detection of 200 P.falciparum genes detected per cell. Since mature erythrocytes are 
transcriptionally inactive, I reasoned that higher proportion of the reads must map towards the 
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parasite reference genome in comparison to the host. In line with this an average 66.92% of 
the total reads mapped to P.falciparum and 33.08% to human genome in the scRNA-seq 
libraries. One of the emerging techniques in scRNA-seq field is integration of datasets from 
different batches or methods (Stuart & Satija 2019; Butler et al. 2018; Haghverdi et al. 2018). 
I tried to align our gene expression alongside the two other published single cell data (Poran 
et al. 2017; Reid et al. 2018) using Canonical Correlation Analysis algorithm as implemented 
in Seurat (Butler et al. 2018) but the expression data remained clustered by the lab of origin. 
This is attributable to both biological and technical variations within the data. 
While FACS sorting or droplet microfluidics have become the standard approaches for high 
throughput isolation of single cells here we used an automated CellSorter (Környei et al. 
2013) to pick the mitotracker stained infected erythrocytes. The merit with this approach is it 
afforded us the ability to discriminate non-singly infected RBCs and the minimal pressure 
was useful for preventing the rapture of the delicate RBCs. Great care was observed to ensure 
the parasites were isolated within 30 minutes of removal from culturing conditions to ensure 
RNA integrity.  
Overall this study provides an initial demonstration that scRNA-seq can be useful in 
understanding the molecular basis of the disease at a cellular level. It opens up the possibility 
of investigating several rare phenotypes of malaria such as sexual commitment, cytoadhesion 
and clonal variation. Possibilities of studying Plasmodium species (such as P.vivax) that are 
uncultivable in the lab could be realized with further optimization. 
5.2 PAPER II 
Even though scRNA-seq contributes immensely to the enumeration of distinct cell types, 
subtypes and states in mammalian cells, studies assessing the impact of different parameters 
in the subpopulation discovery workflow are lacking. In this study, we set out to define the 
limits of uncovering such subgroups using a simulation strategy that enabled tracking the 
magnitude of difference between two subpopulations while retaining the intrinsic properties 
of scRNA-seq data. Here, we used existing published single cell expression data from mouse 
embryonic stem cells (Ziegenhain et al. 2017).  While studies have simulated scRNA-seq 
using parametric models (L Lun et al. 2016; Zappia et al. 2017; Kharchenko et al. 2014; 
Vieth et al. 2017) for the goal of appropriate differential expression analysis, testing 
algorithms performance and modeling technical noise, these studies assumed models that 
may both not capture the full complexity and dependencies in scRNA-seq data, and they 
might also be unequally suited for different kinds of scRNA-seq methods. For instance, my 
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attempts at using Smart-seq2 data from mESCs to infer parameters then simulate scRNA-seq 
data using the Gamma-poisson model in splat (Zappia et al. 2017) or the mean-variance 
model with local polynomial regression (Vieth et al. 2017) both resulted in marked reduction 
in the complexity of the simulated data in comparison to the real data. Hence, we reasoned 
that by partitioning cells into two groups and perturbing a subset of genes in one of them by 
matching them to the expression of highly or lowly expressed genes, we not only establish 
the subpopulations from a homogenous group but also retain the complexity and other 
properties such as dropout rates and variability. By adopting this approach, we did not have to 
assume any distribution models, and our strategy would be equally suitable to all kinds of 
scRNA-seq data. We also avoided the comparison of datasets with mixed batches where the 
effects were evident since this is still an active field of research. While batch correction 
techniques have been proposed and used in different scRNA-seq analysis, the robustness of 
these algorithms is not clear. For instance, using regression methods as implemented in 
Seurat (Butler et al. 2018), SVA-based techniques (Jaffe et al. 2012) and Bayesian approach 
as implemented in ComBat (Johnson et al. 2006) resulted in some negative values in the 
normalized gene expression matrix which would be challenging to process downstream. The 
downside of using single batches in the analysis is the limited number of cells in all the 
methods except Smart-seq2.    
We evaluated the impact of seven different parameters in subpopulation discovery workflow 
namely: protocols, dimensionality reduction, normalization techniques, top variable genes 
cut-offs, clustering methods and total number of cells. Our analysis included six common 
scRNA-seq protocols, three key dimensionality reduction techniques and several 
normalization strategies. In our approach we adopted the popular approach of using of top 
variable genes to discover subpopulations of cells. We confirm that sensitive scRNA-seq 
protocols (such as SCRBseq, CEL-seq2 and Smart-seq2) outperform non-sensitive ones 
(Drop-seq, MARS-seq and Smart-seq). This was especially true when low- to intermediate- 
expressed genes were perturbed. Intriguingly, the full transcript coverage techniques (Smart-
seq and Smart-seq2) generated lower cluster scores than the other four protocols when highly 
expressed genes were perturbed. We speculated that this trend might be driven by a change in 
the gene variability as quantified by coefficient of variance (CV). However, this was not 
apparent from comparing the protocols data. Each protocol’s expression data had ERCC 
spike-ins but I opted not to use them in identifying the most variable genes. This decision was 
informed by the fact that synthetic spike-ins have several drawbacks and may not be 
reflective of the endogenous genes properties (Svensson et al. 2017). Their properties could 
be non-reflective of the endogenous transcripts (e.g. shorter polyA tails in ERCC’s spike-ins), 
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cannot track any variations that occur before the reverse transcription step and are usually 
technically challenging to calibrate especially for small cells with minute amounts of RNA. 
Manifold-based visualization techniques in combination with Principal Component Analysis 
(PCA) generated the most sensitive separation of sub-populations. Interestingly, applying 
manifold methods directly to the top variable genes was poor at delineating the simulated 
subpopulations and this may demonstrate their limitation when only marginal differences 
exist between the subpopulations.   
For normalization, single cell tailored normalization methods (mainly linnorm) outperformed 
bulk-RNA-seq approaches (such as RPKM, TMM), particularly when the magnitude of 
difference between sub-populations was small. Reassuringly, when the perturbation 
magnitude was large all cluster scores were high independent of the normalization approach. 
This shows that the use of normalization methods might only improve sub-type discovery 
within a window where subtle but distinct biological variation between types are present. 
The number of perturbed genes required to delineate sub-populations varied based on their 
level of expression, protocol and magnitude of modification. Interestingly, we discovered that 
for lowly to intermediately expressed genes high level of perturbation was needed (in terms 
of numbers of genes or the fold expressions alterations) for interpretable sub-clusters to 
emerge. This may illustrate the challenge in delineating such groups of cells using the current 
scRNA-seq workflows.  
In terms of the number of most variable genes to use for the discovering the subpopulations 
500 provided the right balance between sensitivity and specificity in capturing the perturbed 
genes in the most variable genes at different degrees of perturbations. 
Overall this analysis reveals the substantial differences between subpopulations that would 
escape detection, irrespective of the scRNA-seq protocol and the normalization technique. 
We also describe how other common parameters in the unsupervised workflow affect the 
subgroups discovery.  
5.3 PAPER III 
Metastatic spread from primary to secondary distal organs and subsequent metastatic tumor 
growth is responsible for more than 90% of cancer mortalities. Compelling evidence 
implicate epithelial-to-mesenchymal transition (EMT) as a driving mechanism of metastasis 
(Ye et al. 2015; Dongre & Weinberg 2019). In this study, we collaborated with Jonas Fuxe’s 
lab to establish an in vivo EMT model in mice to investigate the molecular programs 
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occurring during long-term metastatic growth and role of EMT. We demonstrate that 
Transforming Growth Factor beta I (TGF-ßI) is a potent inducer of mesechymal phenotypes 
in oncogenically primed epithelial cells (EpRas cells) and that autocrinal activity of this 
cytokine stimulates higher metastatic potential than paracrinal mode of action in epithelial 
cells. In our experimental setup, EpXT and EpRas-TGF-ßI may mirror the TGF- autocrinal 
and paracrinal mode of action. Using BALB/c mice with an intact immune system allowed 
for the immune interaction in cancer unlike majority of studies that use immune deficient 
murine models.    
We observe an increased adhesion and metastatic burden in murine lungs and poor survival 
curves for TGF-ß1 treated cells with tumor-seeding potential. While the three distinct 
oncogenic cell lines corresponding to autocrinal TGF-ß1 (EpXT), paracrinal TGF-ß1(EpRas-
TGF-ß1) and none TGF-ß1 treated (EpRas) have distinguishing transcriptional profiles in 
vitro, this is lost in vivo with the intermixing in PCA and tSNE subspace. Importantly, all cell 
lines established a mesenchymal characteristic irrespectively of their EMT status before 
injection into mice, and even after 8 days of metastatic growth they had maintained this 
phenotype. Although a few cells, mostly of EpRas origin, had more epithelial characters in 
the metastatic organ, we cannot determine whether such cells were colonizing and growing in 
the lung together with the cells that had undergone EMT, or whether these cells transited 
back from a MET (mesenchymal to epithelial transition) in the lung. For such resolution, we 
would need to simultaneously adopt lineage-tracing strategies.  
5.4 PAPER IV 
The cancer stem cell hypothesis postulates that malignant cells are hierarchically organized in 
a tissue-like fashion. At the top, a small subpopulation of cancer stem cells (CSCs) 
propagates through self-renewal and differentiation into non-tumorigenic cancer cells that 
form the tumor mass. While the existence of CSCs in hematological malignancies and some 
solid tumors had been established in vitro and in murine models up until this study, their 
existence in human malignancies had been debated. Our main collaborators at Oxford 
isolated and then molecularly and functionally characterized CSCs in myelodysplastic 
syndrome (MDS-SCs) patients with low- and intermediate- risk MDS. Using our in-house 
computational pipelines and the Smart-seq protocol (Ramskold et al. 2012), we profiled an 
ensemble of the MDS-SCs and progenitors compartments. PCA analysis established that the 
MDS-stem and progenitors distinctly separated on the first and second components with over 
50% of the variance captured. This provided further evidence that MDS-SC and the 
progenitors had unique molecular phenotype even at the transcriptome level. 
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6 CONCLUSIONS AND FUTURE PERSPECTIVES 
The maturity of scRNA-seq and the simultaneous analytical computational methods has 
transformed the field from a proof of concept endeavor to the pursuit of mechanistic basis of 
intriguing biological questions. In this thesis I have presented our efforts in using the 
technology to deepen the understanding of parasite biology and EMT-driven cancer 
metastasis. In spite of this remarkable progress fascinating but equally challenging biological 
and technical research questions remain to be addressed.  
With the current goal of eliminating malaria (Winzeler et al. 2016) advanced molecular 
understanding of some of the rare but clinically important phenotypes during infection would 
be significant. These include: iRBCs cytoadhesive processes (such as rosetting, 
sequestration), sexual differentiation, non-symptomatic infections and drug resistance, among 
others. The recent studies (Poran et al. 2017; Reid et al. 2018) and our paper I marked the 
application of scRNA-seq towards IDC and sexual commitment.  This has provided 
significant evidence on the viability of this technology to enhance the genome-wide 
understanding malaria disease. However there are still key questions. Recent finding that one 
of the earliest markers of commitment pfGEXP5 can occur independently of PfAp2-G 
activation, the hitherto presumed master regulator of sexual differentiation, implies the 
existence of alternative mechanism(s) for gametocyte generation (Henry et al. 2019). This 
opens up potential areas of exploration e.g. when exactly does commitment occur? How does 
it vary across different isolates both lab-adapted and from the field? What are determinants of 
the gametocyte sex? What are the genetic and molecular drivers of drug response differences 
between male and female gametocytes? Which are the key determinants of gametocytes 
survival within the mammalian?  
Cytoadhesion of iRBCs to the vasculature and rosetting are mediated by the clonally variant 
surface proteins and confer virulence to the parasite (Wahlgren et al. 2017). However 
exhaustive understanding of the mechanisms driving these critical phenotypes is unknown. 
For instance it has been shown that rosetting, varies between parasite strains and human 
blood types (Wahlgren et al. 2017) but the underlying mechanism is yet to be untangled. In 
the future it will be important to thoroughly describe how these phenotypes are 
transcriptionally regulated in both lab-adapted and field isolates of the parasite. It will be 
important to elucidate the switching mechanism of these surface variants between clones, 
which is an essential strategy adopted by the parasite to evade the immune system. With the 
recent founding of combinatorial index techniques such as sci-RNAseq (Cao et al. 2017), 
which do not need specialized equipment, real time analysis of malaria patients samples in 
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some of the resource limited settings may lead to improved understanding of the disease. 
However these combinatorial indexing methods are just starting to generate results in 
mammalian and model organisms and remain unexplored in infectious diseases hence further 
optimization will be needed. With sequencing technologies becoming cheaper and platforms 
such as Oxford Nanopore ONT emerging then single cell technologies may further expand to 
tackle malaria in the field. The prospects of long reads sequencing to enable the generation of 
splicing isoforms and other allelic variants may facilitate a comprehensive understanding of 
the important clonally driven phenotypes.  
Cells spatial context is important in defining its function and form (Crosetto et al. 2015; 
Yosef & Regev 2016). For instance in cancer, tumor microenvironment can have an impact 
on the metastatic potential of tumorigenic cells (Shibue & Weinberg 2017). The invasive 
cells on the tumor edges may be influenced by a distict microenvironment from the core 
malignancy cells due to the infiltrating exogenous cells. However, current high throughput 
scRNA-seq protocols require the dissociation of cells from primary tissue leading to loss of 
spatial dimension. There have been attempts to integrate spatial cues from a few markers to 
define the cells contexts using algorithms such as Seurat and Achim et al (Satija et al. 2015). 
However these approaches cannot be used in novel cases where cells are not clearly 
demarcated, are without known markers and in stances where there is spatial mix in sub-
populations e.g. cancerous tissue.  The emergence of elegant techniques such as MERFISH 
(Chen et al. 2015; Moffitt et al. 2018) will facilitate spatially resolved gene expression 
profiling and allow for the contextual interpretation of cellular processes. For instance in 
cancers way begin to understand how the different subpopulations (CSCs, stromal cells, 
infiltrating immune) respond to the varying microenvironment? Do the leading metastatic 
cells differ from the core cancer cells? How do the different cancers differ within tissues?  
The emergence of multi-omics techniques combining various entities in the gene expression 
pathway will facilitate a truly integrated examination of cells. Already combining scRNA-seq 
and epigenomics techniques (sc-ATAC-seq, sc-CHIP-seq, chromosome conformation) are 
promising to unravel the epigenetic mechanisms controlling key biological processes. The 
combination of proteomic (mass spectrometry and CITE-seq) and transcriptomics 
technologies is also emerging. Though in its nascent years integrative technologies promise 
deliver an augmented and comprehensive view of biological processes.  
Co-morbidities are commonplace in populations and these can involve disparate diseases. For 
instance cancer and malaria even though been studied separately these two diseases have 
concealed interactions (Nordor et al., 2018). With the rise of cancer incidences in malaria-
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endemic regions an integrative approach to understanding the involved diseases would be 
revolutionary. This may become feasible with the emerging sensitive and integrative 
technologies. In certain instances understanding the potential connections might motivate 
novel approaches for treatment, diagnosis and management. For instance a proof of concept 
that Var2CSA can be used to isolate/enrich for CTCs has been demonstrated (Agerbæk et al. 
2018). 
With technological breakthroughs in the offing, tackling some of the most fascinating 
problems will continue impacting life sciences.  
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